Vedolizumab (#1074)
Laufzeit: 01.01.2020 - 31.12.2020
imported
Kurzfassung
Vedolizumab in the prophylaxis of intestinal acute graft vs host disease in subjects undergoing allogeneic hematopoietic stem cell transplantation.
Laufzeit: 01.01.2020 - 31.12.2020
Vedolizumab in the prophylaxis of intestinal acute graft vs host disease in subjects undergoing allogeneic hematopoietic stem cell transplantation.
